Sean Smith - Insider Trading & Ownership

Entity
Individual
Location
C/O Neoleukin Therapeutics, Inc., 188 E. Blaine Street, Suite 450, Seattle, WA
Summary
The estimated net worth of Sean Smith is at least $15K dollars as of August 14, 2023. Sean Smith is the Interim CFO, Prin Acct Off of Neoleukin Therapeutics, Inc. and owns shares of Neurogene Inc. (NGNE) stock worth about $15K.
All Insider Reports
All Insider Reports

Ownership of Sean Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NGNE Neurogene Inc. Interim CFO, Prin Acct Off $15K Aug 10, 2023

Insider Transactions Reported by Sean Smith:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.